PTGS2 and gastric cancer: Taking the year of GC diagnosis as reference (2.2 %), COX-2 methylation levels were significantly increased at 1–4 years ahead of clinical GC diagnosis (3.0 %, p = 0.01), and decreased at 1–4 years after GC diagnosis (1.9 %, p = 0.80).